title: Ecstacy: a review of MDMA and MDA.
abstract: The Drug Enforcement Administration classified the drug methylenedioxymethamphetamine, MDMA, also known as Ecstacy, as a Schedule I controlled substance on July 1, 1985. The controversy surrounding the classification of MDMA is related to the question of its efficacy as an adjunct to psychotherapy and the larger issue of how to regulate the production and use of designer drugs. The authors review the literature on MDMA and its predecessor, MDA, a substance that differs from MDMA by one methyl group.
mesh_terms: D015104:3,4-Methylenedioxyamphetamine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000506:poisoning / Q000627:therapeutic use; D000662:Amphetamines / Q000494:pharmacology*; D000818:Animals; D004644:Emotions / Q000187:drug effects; D006801:Humans; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D011613:Psychotherapy
chemical_list: D000662:Amphetamines; D015104:3,4-Methylenedioxyamphetamine; D018817:N-Methyl-3,4-methylenedioxyamphetamine